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Objective: The aim of the current study was to evaluate whether cognitive behavioral group 
therapy has a positive impact on psychiatric, and motor and non-motor symptoms in Parkinson’s 
disease (PD).
Methods: We assigned 20 PD patients with a diagnosis of psychiatric disorder to either a 
12-week cognitive behavioral therapy (CBT) group or a psychoeducational protocol. For the 
neurological examination, we administered the Unified Parkinson’s Disease Rating Scale and 
the non-motor symptoms scale. The severity of psychiatric symptoms was assessed by means of 
the Hamilton Depression Rating Scale, the Hamilton Anxiety Rating Scale, the Brief Psychiatric 
Rating Scale, and the Clinical Global Impressions.
Results: Cognitive behavioral group therapy was effective in treating depression and anxiety 
symptoms as well as reducing the severity of non-motor symptoms in PD patients; whereas, no 
changes were observed in PD patients treated with the psychoeducational protocol.
Conclusion: CBT offered in a group format should be considered in addition to standard drug 
therapy in PD patients.
Keywords: Parkinson’s disease, cognitive behavioral group therapy, psychoeducation, motor 
symptoms, non-motor symptoms
Introduction
Parkinson’s disease (PD) is a neurological disorder mainly characterized by 
bradykinesia, rigidity, and tremor. The majority of PD patients also experience non-
motor and psychological symptoms, including depression, anxiety, apathy, psychosis, 
and impulse control disorders.1,2 Depressive and anxiety symptoms occur in up to 50% 
of PD patients and are also associated with poorer quality of life.3,4
Cognitive behavioral therapy (CBT) is one of the most well-established interven-
tions in reducing both depression and anxiety. Several studies have investigated the 
efficacy of individual CBT on psychiatric disorders in PD.5,6 By contrast, only a handful 
of studies have evaluated the efficacy of CBT groups on psychiatric disorders in PD 
patients.5–9 Group CBT may be useful in the adaptation process in patients affected by 
a chronic degenerative disease. In PD, the disease may elicit psychological reactions 
that are expressed in the form of phenomena of biological activation, and of subjective 
experiences of behavioral reactions and psychiatric symptoms (particularly anxiety and 
depressive symptoms). In a previous open study, in which we investigated the effect 
of a group CBT intervention in PD patients, we found that group CBT was useful for 
treating psychiatric and neurological symptoms.10 However, the efficacy of group CBT 
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in PD patients needs to be confirmed by controlled studies. 
Currently, no study has compared the effects of group CBT 
with the effect produced with a psychoeducational protocol 
in PD patients. In view of earlier findings of the efficacy 
of individual and group CBT, we conducted a clinical study 
to investigate the effect of group CBT in PD patients and we 
compared the results with those obtained with PD patients 
treated with a psychoeducational protocol. 
The primary outcome of the study was to assess the 
possible improvement in psychiatric symptoms as measured 
by several rating scales in CBT group therapy and psycho-
educational intervention. The secondary outcomes were the 
effect of CBT group therapy and psychoeducational interven-
tion on motor and non-motor symptoms in PD patients.
Methods
We recruited 20 PD patients from the outpatient clinic for 
Movement Disorders of the Department of Neurology and 
Psychiatry, Sapienza University of Rome, Rome, Italy. 
Patients were enrolled if they had a psychiatric diagnosis 
based on the Structured Clinical Interview for Diagnostic 
and Statistical Manual of Mental Disorders (DSM)-IV Axis I 
Disorders (SCID-I). Exclusion criteria included comorbid 
psychiatric diagnoses of Axis-I psychotic disorders and bipolar 
disorder, as well as an education level of less than middle high 
school. We also excluded patients with possible substance use 
disorders (Figure 1). After a complete description of the study, 
written informed consent was obtained from all the patients. 
The local ethics committee approved the study (Ethical Com-
mittee Sapienza University of Rome). Participants received the 
study treatment at no cost. Psychiatric and neurological evalu-
ations were performed before and after the interventions.
The diagnosis of PD was made according to the European 
Federation of Neurological Society and Movement Disorders 
Society criteria.11 The severity of PD was scored according 
to the Hoehn and Yahr (HY) Scale,12 the severity of motor 
symptoms was assessed by means of the Unified Parkinson’s 
Disease Rating Scale, part III (UPDRS-III)13 and the quality 
of life was assessed using the Parkinson’s Disease Quality 
of Life Questionnaire (PDQ8).14 Non-motor symptoms 
(NMS) were assessed by means of the Non-Motor Symptom 
Scale.15 Cognitive function was measured using the Montreal 
Cognitive Assessment Scale (MoCA)16 and the Frontal 
Assessment Battery Scale (FAB).17 To be able to conduct a 
reliable SCID-I,18 we only enrolled patients without evidence 
of cognitive impairment (MoCA score .26).
The psychiatric evaluation was performed by two 
trained psychiatrists and was based on the SCID-I for 
Axis-I disorders and the SCID-II for Axis-II disorders. 
The severity of psychiatric symptoms was assessed by the 
Hamilton Depression Rating Scale (HAM-D),19 the Hamilton 
Anxiety Scale (HAM-A),20 the Brief Psychiatric Rating Scale 
(BPRS),21 and the Clinical Global Impressions (CGI).22 To 
assess the severity of depressive and anxiety symptoms, 
we used the cut-off scores recommended for the HAM-D-7 
(8–13, mild; 14–18, moderate; $19, severe) and for the 
HAM-A (#17, mild; 18–24, moderate; $24, severe). All of 
the PD patients were diagnosed with a psychiatric disorder. 
Apathy was rated using the apathy evaluation scale.23
Patients were pseudorandomized to one of the two groups 
of treatment by matching duration and severity of Parkinson 
disease and homogeneity in psychiatric clinical diagno-
sis. In our study, 10 of the 20 PD patients were assigned 
to group CBT and 10 to the psychoeducational protocol 
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Figure 1 Participants’ flow diagram.
Abbreviations: cBT, cognitive behavioral therapy; Moca, Montreal cognitive assessment scale; sciD, structured clinical interview for DsM-iV.
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(psychoeducational group). The neurological and psychiatric 
evaluations were performed at baseline and at the end of 
the group intervention (12 weeks) in the group CBT, and at 
baseline and at the end of the psychoeducational intervention 
in the psychoeducational group (12 weeks). The baseline 
and final assessments were conducted by a neurologist and 
psychiatrist who were blind to the type of intervention.
cBT group
A CBT-trained psychiatrist and a neurologist conducted the 
CBT sessions. The CBT intervention consisted of 12 weekly 
90-minute sessions of group therapy.24 The therapists 
involved in the CBT group received weekly supervision 
and training. The group CBT administered to the patients 
was standard group CBT,25,26 the only difference being that 
attention was paid to the link between psychological distress 
and physical illness.27,28 Important elements of the group CBT 
sessions included a convincing rationale for the intervention, 
training in practical skills to change mood-related thoughts, 
behaviors and PD motor symptoms, an encouraging practice 
of the skills outside the therapy sessions, and the attribution 
of improvement to the use of the skills.29 We also evaluated 
specific aspects, including the tendency to avoid social situ-
ations, family conflict, and low levels of assertiveness and 
self-sufficiency. In addition, several sessions were devoted 
to problem-solving, coping strategies, and modeling.30
Psychoeducational group
The psychoeducational group met every 2 weeks. A psy-
chiatrist and a neurologist (different from those who con-
ducted the CBT group) conducted the psychoeducational 
sessions. The interventions focused on information and 
explanations concerning the neurological disease and the 
possible effects on patients’ psychological world. Four main 
areas were targeted: illness awareness; adherence to treat-
ment; early detection of motor and non-motor symptoms; and 
lifestyle regularity. Each session began with a 30–40 minute 
presentation on the topic of the day, followed by a related 
exercise and concluded with a group discussion. Although 
the principal goal of psychoeducation for PD was to provide 
accurate and reliable information regarding the disease 
course and therapeutic strategies, additional objectives 
included teaching patients’ self-management skills and 
helping them make informed decisions about their own 
management within the context of a collaborative working 
relationship with their clinical team. Some sessions were 
focused on side effects of PD medication. Other sessions 
included an explanation of motor complications and other 
side effects, such as impulsive and compulsive behavior, 
hallucinations, and delusions. When possible, psychoedu-
cational interventions were also personalized, for example, 
by taking into account the individual’s unique pattern of 
illness, their risk factors for relapse, and their current social 
circumstances.
All variables are expressed as mean ± SD. Differences 
in age, years of education and gender between PD patients 
allocated to the CBT group therapy and PD patients allocated 
to the psychoeducational group were evaluated by means of 
the Mann–Whitney U test. Non-parametric tests (ie, Mann–
Whitney U test and Wilcoxon sum square test) were used 
to identify potential differences between the two groups in 
the mean baseline values of the psychiatric and neurological 
rating scales, and to identify any differences within each 
group in the psychiatric and neurological rating scale scores 
before and after the interventions. Bonferroni’s correction 
was applied to multiple comparisons. All p-values #0.05 
were considered statistically significant. Data were analyzed 
using SPSS version 13.0.
Results
One of the 10 patients assigned to the group CBT, and one 
of the 10 patients assigned to the psychoeducational group 
did not complete the protocol. Therefore, we analyzed data 
for nine patients in the CBT group and nine patients in the 
psychoeducational group who participated in all the sessions 
of the study (Table 1). 
Table 1 Demographic and clinical data of patients with Parkinson’s 
disease who completed the interventions
CBT group
N=9
Psychoeducational 
group
N=9
age (years) 60.5±5.6 57.1±5.3
gender 6M/3F 5M/4F
education (years) 13.7±7.4 12.4±7.7
Disease duration 
(years)
7.1±32.4 5.2±2.0
hoehn and Yahr 
scale
all patients stage ii all patients stage ii
Moca 29.2±0.9 28.8±1.6
FaB 17.7±0.4 17.2±1.3
sciD-i Depressive disorders: 
2 pts
Depressive disorders: 3 pts
adjustment disorder: 
3 pts
adjustment disorder: 3 pts
anxiety disorders: 4 pts anxiety disorders: 2 pts
Pathological gambling: 1 pt
sciD-ii No diagnosis No diagnosis
Note: Data presented as mean ± sD.
Abbreviations: cBT, cognitive behavioral therapy; Moca, Montreal cognitive 
assessment scale; FaB, Frontal assessment Battery scale; sciD-i, structured 
clinical interview for DsM-iV axis i Disorders; sciD-ii, structured clinical 
interview for DsM-iV axis ii Disorders; DsM-iV, Diagnostic and Statistical Manual of 
Mental Disorders, version IV; F, female; M, male; pts, patients. 
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Patients being treated with antiparkinsonian drugs 
continued their treatment throughout the study, and all of 
the patients were examined while they were on their usual 
drug treatment regimen. One patient in the group CBT and 
one in the psychoeducational group had been on antide-
pressant therapy for approximately a year prior to starting 
the study; this medication treatment continued unchanged 
throughout the study.
Neurological features before and after 
interventions
There were no differences in UPDRS-III and NMS scores at 
baseline among patients who underwent the CBT treatment 
and those who were randomized to the psychoeducational 
protocol (Tables 1, S1, and S2). There were also no dif-
ferences found in UPDRS scores between the two groups 
at the end of the two treatments (Table 2). The NMS total 
score improved significantly in the CBT group, but not in 
the psychoeducational group (Table 2). There were no sig-
nificant differences before and after CBT therapy in any of 
the variables of the NMS scale, and only differences in the 
total score were significant.
Psychiatric features before and after 
interventions
At baseline evaluation, psychiatric diagnoses based on the 
SCID-I interview revealed that patients randomized to the 
CBT treatment and patients randomized to the psychoedu-
cational protocol had similar psychiatric burden (Table 1). 
Similarly, the severity of psychiatric symptoms was also 
comparable between patients who participated in the CBT 
treatment and those who participated in the psychoeduca-
tional treatment (Table 3). The SCID-II interview did not 
reveal any diagnoses in either group.
The HAM-A scores, the HAM-D scores, and the BPRS 
scores improved significantly in the CBT group from baseline 
to the end of the treatment; whereas, these symptoms did not 
decrease among PD patients in the psychoeducational group 
(Table 3). The apathy score also improved significantly in 
the CBT group (Table 3). Regarding the CGI scores, in the 
CBT group at baseline, three patients had a score of 4, and 
six patients had a score of 6; whereas at the end of treatment, 
five patients had a score of 3, three patients a score of 2, and 
one patient had a score of 0. In the psychoeducational group, 
at baseline four patients had a score of 4 and five patients had 
a score of 3, and the scores remained unchanged at the end 
of the treatment. When assessing individual scores on the 
psychiatric rating scales and the CGI scores, we found that 
all participants in the CBT group improved; whereas, scores 
in these domains for participants in the psychoeducational 
group remained stable.
Discussion
The results of our study demonstrated that among PD 
patients in the CBT group, scores on the HAM-A decreased 
by 30%, HAM-D scores decreased by 22%, BPRS scores 
were reduced by 18.0%, and apathy score decreased by 
15%, revealing that all patients treated with group CBT 
improved with regard to their psychiatric functioning. NMS 
scores were also significantly improved in the CBT group. 
Conversely, no changes in these measures were observed 
in the psychoeducational group. We also found that the 
Table 2 effect of cBT and psychoeducational interventions on neurological symptoms and quality of life
UPDRS-III Non-motor symptom scale PDQ8
Baseline Final Baseline Final Baseline Final
cBT group (N=9) 18.1±7.9 17.1±7.4 21.6±15.5 19.1±14.3* 7.4±4.5 6.3±2.8
Psychoeducational group (N=9) 18.4±3.6 19.5±5.9 18.6±20.2 21.1±20.2 9.1±3.0 10.3±3.4
Notes: No significant differences at baseline between the two groups in any of the scales used. No significant differences in scores between baseline evaluation and final 
evaluation in the UPDrs-iii and PDQ8 scales. *p=0.041, z=-2.041 (Wilcoxon signed rank tests). Data presented as mean ± sD.
Abbreviations: CBT, cognitive behavioral therapy; UPDRS, Unified Parkinson Disease Rating Scale; PDQ8, Parkinson’s Disease Quality of Life Questionnaire.
Table 3 effect of cBT and psychoeducational interventions on psychiatric rating scales
HAM-A HAM-D BPRS Apathy
Baseline Final Baseline Final Baseline Final Baseline Final
cBT group 25.6±7.5 17.9±6.0* 21.7±8.2 17.0±6.8** 34.3±3.7 28.1±4.2* 16.4±7.6 13.9±6.9**
Psychoeducational group 22.2±8.6 22.0±8.5 20.9±7.4 20.7±7.2 32.4±4.5 32.7±4.5 13.1±4.7 14.7±5.3
Notes: comparing scores obtained at the end of treatment versus scores obtained at baseline. *p,0.01, z=-2.677; **p,0.05, z=-2.546. Data presented as mean ± sD.
Abbreviations: cBT, cognitive behavioral therapy; haM-a, hamilton rating scale for anxiety; haM-D, hamilton rating scale for Depression; BPrs, Brief Psychiatric 
rating scale.
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UPDRS-III did not change significantly following the CBT 
group intervention or the psychoeducational group. 
All the patients were diagnosed with a psychiatric dis-
order according to the SCID-I, and the patients’ HAM-A, 
HAM-D, and BPRS scores were all above the cut-off and 
considered pathological. Therefore, it is unlikely that the 
differences between the CBT and the psychoeducational 
group were due to the variation in clinical severity of 
psychiatric disturbances.
The results of the present study are in keeping with 
those of previous studies investigating individual CBT for 
depression in PD patients.5 Few studies have evaluated the 
efficacy of group CBT for psychiatric symptoms among indi-
viduals with PD. Two such studies without a control group 
showed an improvement in anxiety and depression symptoms 
following group CBT;10,31 whereas other studies used a wait-
list control group.32,33 Our study demonstrated that group 
CBT improves psychiatric symptoms in PD patients when 
compared to those receiving a psychoeducational interven-
tion. Our study therefore confirms that group CBT improves 
psychiatric symptoms in PD patients also when compared 
with a psychoeducational intervention. The CBT group 
therapy began with a brief summary of the aims of the group 
and the rationale for learning what would be taught during 
the sessions. Each session focused on a specific set of skills. 
The first level of CBT group therapy consisted of modifying 
specific thoughts and behaviors.34 This level included identi-
fication of thoughts and behaviors with potentially positive or 
negative effects on mood, and the identification of PD motor 
symptoms associated with mood and anxiety changes. The 
second level included learning self-instructional methods, 
which allowed the patients to start taking over the function 
previously played by the therapist.35 The third level focused 
on logical analysis and was based on methods similar to 
those developed by Ellis,36 and, later, by Beck et al.37 At this 
level, the patients question the logic of taking certain facts, 
values or perspectives for granted, and consider alternative 
ways of interpreting their own experiences.38 Some sessions 
were aimed at understanding the patients’ vulnerability and 
their fear of the future.
A further novel finding of our study is the improvement 
in NMS in patients treated with group CBT. NMS in PD 
include neuropsychiatric symptoms, autonomic dysfunction, 
sleep disorders, fatigue, and pain. Among patients with PD, 
the presence and severity of NMS is associated with poorer 
quality of life, nevertheless few studies have investigated 
the effect of specific treatments addressing these disabling 
symptoms.39 The finding that group CBT improved NMS 
scores while psychoeducational therapy did not, suggests 
that group CBT is a useful therapeutic approach which 
should be considered in the treatment of PD patients. It is 
important to note that NMS improved in a general way, and 
improvement was not due only to changes in the scores of 
neuropsychiatric symptoms.
In this study, we used a group therapy approach to allow 
patients suffering from the same neurological disorder 
(ie, PD) to interact with each other in an organized manner 
on the basis of shared experiences, fears, and expectations. 
In this framework, the group has a personal experience and 
evolution, a social space that promotes the development of 
relations between individuals that belong to the group.40 
The therapeutic factors of group therapy are the universality, 
the acquisition of new information, the infusion of hope and 
altruism, the enhancement of socialization techniques, imi-
tative behavior, interpersonal learning, group cohesion and 
the psychological adaptation to the presence of an organic 
neurological pathology.41 Patients with chronic neurological 
diseases tend to experience an increased degree of stigma, 
withdrawal, and social isolation, which play a significant 
role in both the development and persistence of psychiatric 
comorbidity.42 The exchange of information, the development 
of socializing techniques, self-disclosure, shared cognitive 
analysis of emotions and restructuring techniques create a 
sense of cohesion and belonging.43–47 The recognition by 
individuals within the same group of both similarities and 
differences enhances the development of functions as well 
as of metacognitive skills. In PD patients, group CBT can 
provide a particularly powerful sense of universality and 
cohesion that reduces the sense of stigma and isolation 
through direct social support,48 whereas, the psychoeduca-
tional program in a group setting allows patients to obtain 
information and share their concerns, with the attention dedi-
cated to other patients creating a climate of shared hope. 
In recent years, many studies have shown the effective-
ness of psychoeducational programs for treating psychi-
atric disorders and have demonstrated the superiority of 
psychoeducational family interventions as compared to 
standard treatments.49 Psychoeducation is a specific type 
of therapy that focuses on educating patients about their 
disorders and ways of coping. This approach has been 
shown to be effective in the prevention and management 
of many psychiatric disorders, psychiatric symptoms in 
medical conditions, and neuropsychiatric disorders.50–52 The 
psychoeducation model used in our study was based on the 
psychoeducational model developed by Carkhuff.53 This 
model has been adapted in order to teach the interpersonal 
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skills of empathy, respect, concreteness, genuineness, self-
disclosure, confrontation, for PD patients with psychiatric 
symptoms. Additionally, structured psychological therapies 
that combine psychoeducation and CBT are being increas-
ingly used in patients diagnosed with a variety of psychiatric 
disorders.54 Psychoeducation is a behavioral therapeutic 
approach which mainly focusses on briefing the patients 
about their illness, problem-solving training, communica-
tion training, and self-assertiveness training. The lack of 
clinical improvement in our PD patients treated with the 
psychoeducational intervention suggests that strategies 
which include cognitive, affective and psychomotor com-
ponents such as the group CBT intervention are more likely 
to change complex behavior patterns influencing mood and 
anxiety symptoms in PD patients than didactic interventions 
which focus on knowledge and concepts of illness, such as 
the psychoeducational program. These changes of complex 
behavior obtained after CBT were indeed associated with 
an improvement in psychiatric symptoms when compared 
with psychoeducation.
Limitations
One limitation of the study is that the psychoeducational 
treatment was not equivalent to the CBT treatment in terms 
of number and duration of sessions. The self-report nature 
of the measures used in the psychiatric evaluation is also 
a limitation together with the relatively small number of 
patients studied. This report suggests that studies on a larger 
population with PD are therefore warranted.
Conclusion
Our findings highlight the potential relevance of a CBT 
group approach for chronic and disabling illnesses such as 
PD. The fact that group CBT was effective in PD whereas 
educational intervention was not, suggests that factors 
intrinsic to CBT therapy, beyond “social support” are at 
play in improving symptoms in PD. Group CBT should 
be considered in addition to standard drug therapy for the 
treatment of mental health symptoms, particularly depres-
sion and anxiety.
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